{"id":"https://openalex.org/W3211073116","doi":null,"title":"Development and validation of reverse phase high performance liquid chromatographic method for quantitative estimation of nefopam in tablet dosage form.","display_name":"Development and validation of reverse phase high performance liquid chromatographic method for quantitative estimation of nefopam in tablet dosage form.","publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W3211073116","mag":"3211073116"},"language":"en","primary_location":{"id":"mag:3211073116","doi":null,"is_oa":false,"landing_page_url":"https://www.alliedacademies.org/articles/development-and-validation-of-reverse-phase-high-performance-liquid-chromatographic-method-for-quantitative-estimation-o.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100604017","display_name":"Rohit Kumar","orcid":"https://orcid.org/0009-0007-2793-489X","observed_orcids":["https://orcid.org/0009-0007-2793-489X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rohit Kumar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041438556","display_name":"Vijay Kumar Munipalli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vijaya Kumar Munipalli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102307314","display_name":"Raman Mohan Singh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raman Mohan Singh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5004457215","display_name":"Sayali Warde","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sayali Warde","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.11640701,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":"7","first_page":"1","last_page":"5"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nefopam","display_name":"nefopam","score":0.9980000257492065},{"id":"https://openalex.org/keywords/quantitative-estimation","display_name":"quantitative estimation","score":0.5569999814033508},{"id":"https://openalex.org/keywords/tablets","display_name":"tablets","score":0.7919999957084656},{"id":"https://openalex.org/keywords/rp-hplc-method-development","display_name":"RP-HPLC method development","score":0.8050000071525574},{"id":"https://openalex.org/keywords/method-validation","display_name":"method validation","score":0.8169999718666077},{"id":"https://openalex.org/keywords/drug-quantification","display_name":"pharmaceutical analysis","score":0.4880000054836273}],"concepts":[{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.8571791648864746},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.6657531261444092},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.6278130412101746},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.5440903902053833},{"id":"https://openalex.org/C154256306","wikidata":"https://www.wikidata.org/wiki/Q41795528","display_name":"Inert","level":2,"score":0.49991679191589355},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.49828624725341797},{"id":"https://openalex.org/C45188465","wikidata":"https://www.wikidata.org/wiki/Q645497","display_name":"Reversed-phase chromatography","level":3,"score":0.48641085624694824},{"id":"https://openalex.org/C2992520659","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatographic separation","level":3,"score":0.4712054133415222},{"id":"https://openalex.org/C95986675","wikidata":"https://www.wikidata.org/wiki/Q185168","display_name":"Quantitative analysis (chemistry)","level":2,"score":0.4599307179450989},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.3615201711654663},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3211073116","doi":null,"is_oa":false,"landing_page_url":"https://www.alliedacademies.org/articles/development-and-validation-of-reverse-phase-high-performance-liquid-chromatographic-method-for-quantitative-estimation-o.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7080464720","https://openalex.org/W7084394755","https://openalex.org/W2366083119","https://openalex.org/W7167635573","https://openalex.org/W2363425322","https://openalex.org/W2383543914","https://openalex.org/W2385260173","https://openalex.org/W2377128010","https://openalex.org/W2271140491","https://openalex.org/W7099978247"],"abstract_inverted_index":{"A":[0],"simple,":[1],"precise":[2],"and":[3],"rapid":[4],"Reverse":[5],"Phase":[6],"High":[7],"Performance":[8],"Liquid":[9],"Chromatographic":[10],"(RP-HPLC)":[11],"method":[12],"has":[13],"been":[14],"developed":[15],"for":[16],"quantitative":[17],"determination":[18],"of":[19],"Nefopam":[20],"in":[21],"tablet":[22],"dosage":[23],"form.":[24],"The":[25],"chromatographic":[26],"separation":[27],"was":[28],"achieved":[29],"on":[30],"Inert":[31],"sustain":[32],"swift":[33],"C18":[34],"column":[35],"(250":[36],"mm":[37]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2021-11-08T00:00:00"}